CJR-X turns LEJR into a permanent financial risk
What CFOs, CMOs and value-based care teams need to know now before CJR-X launches Oct. 1, 2027.
CJR‑X accountability has begun
As of today, LEJR episodes are subject to mandatory CJR‑X reconciliation. Target prices, quality adjustments and regional benchmarks are now live — and preparation time is over.
Hospitals that invested early are positioned to control margins and protect quality. Those that didn’t are now learning in real dollars.
00
days
00
hours
00
minutes
00
seconds
What you don’t prepare for now,
you’ll pay for later
With no opt‑out, no end date and full 90‑day episode accountability, CJR‑X shifts lower extremity joint replacement (LEJR) margins permanently. Download to understand your exposure.
By submitting this form, you’re agreeing to receive the occasional, well-intentioned marketing email from us. We will never share or sell your data.
Built for hospital leaders responsible for LEJR performance
CFOs
Understand financial exposure, stop‑loss limits and regional competitiveness.
CMOs
See how quality, readmissions and care variation affect reconciliation.
Value‑based care teams
Learn where post‑acute management and transitions drive outcomes.
CJR-X is a larger, more complex version of a model we’ve lived with for nearly a decade. This guide gives you expert insights on how to prepare early rather than later.
Your preparation window starts now
Margin exposure
Learn how CJR‑X will directly affect LEJR margins under mandatory, permanent and regionally benchmarked pricing.
Competitive position
Understand how your hospital’s LEJR episodes are likely to perform against regional peers, not historical internal benchmarks.
Downstream risk
See exactly how post‑acute care, readmissions and outpatient utilization drive financial outcomes over the full 90‑day episode.
Pre‑launch actions
Identify the specific steps hospital leadership should take before Oct. 1, 2027 to reduce uncertainty and avoid reactive decision‑making.